One Word Ran Through Every Genetics Conference in 2026
In 2026, 3billion attended six conferences across six countries in person — ACMG in Baltimore, ESHG in Gothenburg, and SSIEM in Helsinki, along with meetings in Taiwan, Kazakhstan, and Guatemala.
Every one of them drew a different region and a different audience. Yet when we gathered the conversations from our booths and the discussions from the sessions, one word kept coming up.
This report covers what that word was, and what was actually being said about it on the ground.
What you’ll find in the report
The year’s major conferences, in one place We’ve pulled together the discussions that stood out most at ACMG, ESHG, and SSIEM. A quick way to get a feel for the meetings you couldn’t attend.
The keyword that ran through all six — and how it landed What the word was, and how the response differed from one conference to the next.
Two recent papers we’ve been following Of the research published this year on that keyword, we picked two and summarized what they found and where they fall short. One sets out a view of where the field is heading; the other works with real clinical data. Useful when you don’t have time to track the literature yourself.
What’s in it
Length 7 pages (PDF)
Every study cited is listed with its source and DOI.
Who this is for
- Laboratories and clinics considering adopting or expanding genomic testing
- Anyone who couldn’t attend this year’s meetings, or made it to only some of them
- Anyone weighing when to bring a new sequencing technology in
Read the full report
Fill in your details below and the report opens right away.
Soo-jung Baek
Marketing Manager
I strive to empower the rare disease community by sharing meaningful insights backed by our company’s expertise.
